Library of CRISPR targeting sequences increases power of the gene-editing method – Phys.Org
Phys.Org |
Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb |
Phys.Org |
Library of CRISPR targeting sequences increases power of the gene-editing method
Phys.Org CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA (blue). The enzyme is directed to its …more. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR LibraryGenomeWeb |
Medical Xpress |
Innate reaction of hematopoietic stem cells to severe infections
Medical Xpress Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide—that is, without signals from growth factors. This direct production of defensive cells damages … |
Technology Networks |
CRISPR Reveals New Targets for Promising Cancer Drugs
Technology Networks redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had … |
ETHealthworld.com |
TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution
ETHealthworld.com July 20, 2017, Mumbai: Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome’s patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against … |
|
Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library
GenomeWeb But while similar approaches have been applied for selecting Cas9 sgRNAs for use with CRISPR, they added, Cas9-induced double-strand breaks (DSBs) leave a “genomic scar whose characteristics determine the phenotypic consequences of targeting a locus … |
UPI.com |
Number of T-cells predicts response to immunotherapy in melanoma
UPI.com “Combination immunotherapy is super-expensive and very toxic,” Dr. Adil Daud, director of Melanoma Clinical Research at the UCSF Helen Diller Family Comprehensive Cancer Center, said in a press release. “You’re putting patients at a lot of extra risk … Immune-cell numbers predict response to combination immunotherapy in melanomaMedical Xpress |